Exosomes derived from DCs treated with interleukin-10 (IL-10) or transfected with the gene for IL-10 can inhibit trinitrobenzene sulfonic acid (TNBS)-induced rat colitis through stimulating CD4+CD25+Tregs (19). The gene discussed is IL10; the disease is colitis.